<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>BioMed Central</PublisherName>
    <PublisherLocation>London</PublisherLocation>
    <PublisherImprintName>BioMed Central</PublisherImprintName>
  </PublisherInfo>
  <Journal OutputMedium="Online">
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>13578</JournalID>
      <JournalElectronicISSN>2045-3701</JournalElectronicISSN>
      <JournalTitle>Cell &amp; Bioscience</JournalTitle>
      <JournalAbbreviatedTitle>Cell Biosci</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="SCL" Type="Primary">Life Sciences</JournalSubject>
        <JournalSubject Code="SCL16008" Priority="1" Type="Secondary">Cell Biology</JournalSubject>
        <JournalSubject Code="SCL23004" Priority="2" Type="Secondary">Microbiology</JournalSubject>
        <JournalSubject Code="SCL16010" Priority="3" Type="Secondary">Stem Cells</JournalSubject>
        <JournalSubject Code="SCL25066" Priority="4" Type="Secondary">Neurobiology</JournalSubject>
        <JournalSubject Code="SCL1403X" Priority="5" Type="Secondary">Proteomics</JournalSubject>
        <SubjectCollection Code="Biomedical and Life Sciences">SC3</SubjectCollection>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume OutputMedium="Online">
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>6</VolumeIDStart>
        <VolumeIDEnd>6</VolumeIDEnd>
        <VolumeIssueCount>1</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular" OutputMedium="Online">
        <IssueInfo IssueType="Regular" TocLevels="0">
          <IssueIDStart>1</IssueIDStart>
          <IssueIDEnd>1</IssueIDEnd>
          <IssueArticleCount>0</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2016</Year>
              <Month>12</Month>
            </CoverDate>
            <PricelistYear>2016</PricelistYear>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>The Author(s)</CopyrightHolderName>
            <CopyrightYear>2016</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="s13578-016-0110-x" OutputMedium="Online">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>110</ArticleID>
            <ArticleDOI>10.1186/s13578-016-0110-x</ArticleDOI>
            <ArticleCitationID>42</ArticleCitationID>
            <ArticleSequenceNumber>42</ArticleSequenceNumber>
            <ArticleTitle Language="En" OutputMedium="All">Bioinformatic analysis reveals the expression of unique transcriptomic signatures in Zika virus infected human neural stem cells</ArticleTitle>
            <ArticleCategory>Research</ArticleCategory>
            <ArticleFirstPage>1</ArticleFirstPage>
            <ArticleLastPage>13</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2016</Year>
                <Month>6</Month>
                <Day>2</Day>
              </RegistrationDate>
              <Received>
                <Year>2016</Year>
                <Month>5</Month>
                <Day>13</Day>
              </Received>
              <Accepted>
                <Year>2016</Year>
                <Month>6</Month>
                <Day>3</Day>
              </Accepted>
              <OnlineDate>
                <Year>2016</Year>
                <Month>6</Month>
                <Day>10</Day>
              </OnlineDate>
            </ArticleHistory>
            <ArticleFundingInformation>
              <Fund>
                <FunderName FundRefID="http://dx.doi.org/10.13039/100000002">National Institutes of Health</FunderName>
                <GrantNumber GrantRecipient="Au5" Type="FundRef">R01GM100474</GrantNumber>
                <GrantNumber GrantRecipient="Au5" Type="FundRef">R01GM072611</GrantNumber>
              </Fund>
            </ArticleFundingInformation>
            <ArticleCopyright>
              <CopyrightHolderName>The Author(s)</CopyrightHolderName>
              <CopyrightYear>2016</CopyrightYear>
              <License SubType="CC BY + CC0" Type="OpenAccess" Version="4.0">
                <SimplePara>
                           <Emphasis Type="Bold">Open Access</Emphasis>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ExternalRef>
                    <RefSource>http://creativecommons.org/licenses/by/4.0/</RefSource>
                    <RefTarget Address="http://creativecommons.org/licenses/by/4.0/" TargetType="URL"/>
                  </ExternalRef>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ExternalRef>
                    <RefSource>http://creativecommons.org/publicdomain/zero/1.0/</RefSource>
                    <RefTarget Address="http://creativecommons.org/publicdomain/zero/1.0/" TargetType="URL"/>
                  </ExternalRef>) applies to the data made available in this article, unless otherwise stated.</SimplePara>
              </License>
            </ArticleCopyright>
            <ArticleGrants Type="OpenChoice">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="OpenAccess"/>
              <BodyHTMLGrant Grant="OpenAccess"/>
              <BibliographyGrant Grant="OpenAccess"/>
              <ESMGrant Grant="OpenAccess"/>
            </ArticleGrants>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" ID="Au1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Alyssa</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>Rolfe</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>alyssa.rolfe@med.fsu.edu</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1" ID="Au2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Dale</GivenName>
                  <GivenName>B.</GivenName>
                  <FamilyName>Bosco</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>dale.bosco@med.fsu.edu</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1" ID="Au3">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jingying</GivenName>
                  <FamilyName>Wang</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>jingying.wang0618@gmail.com</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1" ID="Au4">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Richard</GivenName>
                  <GivenName>S.</GivenName>
                  <FamilyName>Nowakowski</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>richard.nowakowski@med.fsu.edu</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff2" ID="Au5">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jianqing</GivenName>
                  <FamilyName>Fan</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>jqfan@princeton.edu</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1" ID="Au6" ORCID="http://orcid.org/0000-0002-0176-493X">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Yi</GivenName>
                  <FamilyName>Ren</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>850 645 2013</Phone>
                  <Email>yi.ren@med.fsu.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Department of Biomedical Sciences, College of Medicine</OrgDivision>
                <OrgName>Florida State University</OrgName>
                <OrgAddress>
                  <Street>1115 West Street</Street>
                  <City>Tallahassee</City>
                  <State>FL</State>
                  <Postcode>32306</Postcode>
                  <Country Code="US">USA</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgDivision>Statistical Laboratory</OrgDivision>
                <OrgName>Princeton University</OrgName>
                <OrgAddress>
                  <City>Princeton</City>
                  <State>NJ</State>
                  <Postcode>08540</Postcode>
                  <Country Code="US">USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En" OutputMedium="All">
              <Heading>Abstract</Heading>
              <AbstractSection ID="ASec1">
                <Heading>Background</Heading>
                <Para ID="Par1">The single-stranded RNA <Emphasis Type="Italic">Flavivirus</Emphasis>, Zika virus (ZIKV), has recently re-emerged and spread rapidly across the western hemisphere’s equatorial countries, primarily through <Emphasis Type="Italic">Aedes</Emphasis> mosquito transmission. While symptoms in adult infections appear to be self-limiting and mild, severe birth defects, such as microcephaly, have been linked to infection during early pregnancy. Recently, Tang et al. (Cell Stem Cell <CitationRef CitationID="CR9">2016</CitationRef>, doi: <ExternalRef>
                    <RefSource>10.1016/j.stem.2016.02.016</RefSource>
                    <RefTarget Address="10.1016/j.stem.2016.02.016" TargetType="DOI"/>
                  </ExternalRef>) demonstrated that ZIKV efficiently infects induced pluripotent stem cell (iPSC) derived human neural progenitor cells (hNPCs), resulting in cell cycle abnormalities and apoptosis. Consequently, hNPCs are a suggested ZIKV target.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec2">
                <Heading>Methods</Heading>
                <Para ID="Par2">We analyzed the transcriptomic sequencing (RNA-seq) data (GEO: GSE78711) of ZIKV (Strain: MR766) infected hNPCs. For comparison to the ZIKV-infected hNPCs, the expression data from hNPCs infected with human cytomegalovirus (CMV) (Strain: AD169) was used (GEO: GSE35295). Utilizing a combination of Gene Ontology, database of human diseases, and pathway analysis, we generated a putative systemic model of infection supported by known molecular pathways of other highly related viruses.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec3">
                <Heading>Results</Heading>
                <Para ID="Par3">We analyzed RNA-sequencing data for transcript expression alterations in ZIKV-infected hNPCs, and then compared them to expression patterns of iPSC-derived hNPCs infected with CMV, a virus that can also induce severe congenital neurological defects in developing fetuses. We demonstrate for the first time that many of cellular pathways correlate with clinical pathologies following ZIKV infection such as microcephaly, congenital nervous system disorders and epilepsy. Furthermore, ZIKV activates several inflammatory signals within infected hNPCs that are implicated in innate and acquired immune responses, while CMV-infected hNPCs showed limited representation of these pathways. Moreover, several genes related to pathogen responses are significantly upregulated upon ZIKV infection, but not perturbed in CMV-infected hNPCs.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec4">
                <Heading>Conclusion</Heading>
                <Para ID="Par4">The presented study is the first to report enrichment of numerous pro-inflammatory pathways in ZIKV-infected hNPCs, indicating that hNPCs are capable of signaling through canonical pro-inflammatory pathways following viral infection. By defining gene expression profiles, new factors in the pathogenesis of ZIKV were identified which could help develop new therapeutic strategies.</Para>
              </AbstractSection>
            </Abstract>
            <AbbreviationGroup>
              <Heading>Abbreviations</Heading>
              <DefinitionList>
                <DefinitionListEntry>
                  <Term>ZIKV</Term>
                  <Description>
                    <Para ID="Par5">Zika virus</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>iPSC</Term>
                  <Description>
                    <Para ID="Par6">induced pluripotent stem cell</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>hNPC</Term>
                  <Description>
                    <Para ID="Par7">human neural progenitor cell</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>CMV</Term>
                  <Description>
                    <Para ID="Par8">cytomegalovirus</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>GBS</Term>
                  <Description>
                    <Para ID="Par9">Guillain–Barré syndrome</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>GO</Term>
                  <Description>
                    <Para ID="Par10">gene ontology</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>FC</Term>
                  <Description>
                    <Para ID="Par11">fold-change</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>MOZ/MORF</Term>
                  <Description>
                    <Para ID="Par12">monocytic leukemia zinc-finger protein/related factor</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>DEG</Term>
                  <Description>
                    <Para ID="Par13">differentially expressed genes</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>CNS</Term>
                  <Description>
                    <Para ID="Par14">central nervous system</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>HSV-1</Term>
                  <Description>
                    <Para ID="Par15">herpes simplex virus 1</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>HIV</Term>
                  <Description>
                    <Para ID="Par16">human immunodeficiency virus</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>VZV</Term>
                  <Description>
                    <Para ID="Par17">varicella-zoster virus</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>GM-CSF</Term>
                  <Description>
                    <Para ID="Par18">granulocyte–macrophage colony stimulating factor</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>IL</Term>
                  <Description>
                    <Para ID="Par19">interleukin</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>TLR</Term>
                  <Description>
                    <Para ID="Par20">toll-like receptor</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>MyD88</Term>
                  <Description>
                    <Para ID="Par21">myeloid differentiation primary response gene 88</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>TNF</Term>
                  <Description>
                    <Para ID="Par22">tumor necrosis factor</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>IFN</Term>
                  <Description>
                    <Para ID="Par23">interferon</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>CXC</Term>
                  <Description>
                    <Para ID="Par24">C-X-C motif chemokine</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>APC</Term>
                  <Description>
                    <Para ID="Par25">antigen-presenting cells</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>STAT</Term>
                  <Description>
                    <Para ID="Par26">signal transducer and activator of transcription</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>NF-κB</Term>
                  <Description>
                    <Para ID="Par27">nuclear factor kappa-light-chain-enhancer of activated B cells</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>PAMP</Term>
                  <Description>
                    <Para ID="Par28">pathogen-associated molecular patterns</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>JAK</Term>
                  <Description>
                    <Para ID="Par29">Janus kinase</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>COX2</Term>
                  <Description>
                    <Para ID="Par30">cyclooxygenase-2</Para>
                  </Description>
                </DefinitionListEntry>
                <DefinitionListEntry>
                  <Term>iNOS</Term>
                  <Description>
                    <Para ID="Par31">inducible nitric oxide synthase</Para>
                  </Description>
                </DefinitionListEntry>
              </DefinitionList>
            </AbbreviationGroup>
          </ArticleHeader>
          <Body>
            <Section1 ID="Sec1">
              <Heading>Background</Heading>
              <Para ID="Par32">Zika Virus (ZIKV) is a single-stranded positive sense RNA <Emphasis Type="Italic">Flavivirus</Emphasis> [<CitationRef CitationID="CR1">1</CitationRef>] that is primarily transmitted though the <Emphasis Type="Italic">Aedes</Emphasis> mosquito [<CitationRef CitationID="CR2">2</CitationRef>]. Until recently this virus had remained relatively obscure, with the exception of a few scattered outbreaks [<CitationRef CitationID="CR1">1</CitationRef>–<CitationRef CitationID="CR3">3</CitationRef>]. Currently, 26 countries across South and Central America have reported widespread ZIKV infections, with cases also emerging in Europe and the United States [<CitationRef CitationID="CR4">4</CitationRef>]. Typically, adult ZIKV infections are mild or asymptomatic, with exanthema, fever, conjunctivitis, and joint pain being the most common symptoms [<CitationRef CitationID="CR2">2</CitationRef>, <CitationRef CitationID="CR5">5</CitationRef>]. However, ZIKV infection is also believed to be related to the concurrent increase in adult Guillain–Barré syndrome (GBS) cases [<CitationRef CitationID="CR4">4</CitationRef>]. This is supported by a case controlled prospective study of the French Polynesian outbreak, where ZIKV was linked with increased incidence of GBS [<CitationRef CitationID="CR3">3</CitationRef>]. Aside from its effects in adults, ZIKV infection of pregnant women can result in birth defects ranging from low birth weight to craniofacial and eye abnormalities [<CitationRef CitationID="CR6">6</CitationRef>], as well as microcephaly [<CitationRef CitationID="CR7">7</CitationRef>, <CitationRef CitationID="CR8">8</CitationRef>]. The detection of ZIKV in fetal brain tissues indicates that ZIKV can also cross the placental barrier [<CitationRef CitationID="CR9">9</CitationRef>]. Consequently, curbing the current ZIKV epidemic has become a top priority for a number of international health initiatives.</Para>
              <Para ID="Par33">Prompt laboratory-based efforts by Tang et al. provided RNA-seq data (GEO: GSE78711) from ZIKV-infected human neural progenitor cells (hNPCs). They found that when compared to neurons and embryonic stem cells, ZIKV infects hNPCs with high efficiency, and that infection results in abnormal cell cycle dynamics and apoptosis [<CitationRef CitationID="CR9">9</CitationRef>]. For the current study, we analyzed this dataset using bioinformatic methods to uncover links between neuro-inflammatory pathways and ZIKV infection of hNPCs, as well as its correlation with clinical neurological symptoms. Since congenital CMV infection is also associated with higher incidence of neurological birth defects [<CitationRef CitationID="CR10">10</CitationRef>], a CMV-infected hNPC dataset (GEO: GSE19345) was used for comparison [<CitationRef CitationID="CR11">11</CitationRef>]. We demonstrate for the first time that ZIKV activates several inflammatory signals within infected hNPCs that are implicated in both innate and acquired immune responses. Moreover, several genes related to pathogen responses are significantly up-regulated in response to ZIKV infection, but not perturbed in CMV-infected hNPCs. Our approach offers novel insight into the potential mechanisms underlying ZIKV infection and provides useful directions for future clinical research.</Para>
            </Section1>
            <Section1 ID="Sec2">
              <Heading>Results</Heading>
              <Section2 ID="Sec3">
                <Heading>Comprehensive gene set gene ontology analysis</Heading>
                <Para ID="Par34">Comparison of the mock-infected samples to the ZIKV-infected samples using a modified <Emphasis Type="Italic">t</Emphasis>-test yields a total of 3443 genes up-regulated and 3421 down-regulated. The top 30 highest absolute fold-change (FC) genes are reported in Tables <InternalRef RefID="Tab1">1</InternalRef> and <InternalRef RefID="Tab2">2</InternalRef> along with their associated Entrez IDs and p-values. Gene Ontology (GO) term analysis showed that the up-regulated gene set was exclusively enriched in processes related to nucleic acid metabolism regulation (Fig. <InternalRef RefID="Fig1">1</InternalRef>a). Since replication of the viral genome requires reallocation of host nucleotides [<CitationRef CitationID="CR12">12</CitationRef>], this finding was unsurprising. Also, the down-regulated gene set was enriched for DNA metabolism processes, although with emphasis on cell cycle regulation. These findings were consistent with evidence showing ZIKV infection results in the down-regulation of cell cycle genes, impaired cell cycle progression through G<Subscript>1</Subscript> [<CitationRef CitationID="CR9">9</CitationRef>], and decreased proliferation [<CitationRef CitationID="CR13">13</CitationRef>] in vitro. Of the ZIKV down-regulated genes, the biological process most enriched proved to be chromosome segregation. This finding provides an interesting link to known causes of hereditary microcephaly, as abnormal brain development and reduced volume often are the result of dysregulation of chromosome segregation [<CitationRef CitationID="CR14">14</CitationRef>, <CitationRef CitationID="CR15">15</CitationRef>].<Table Float="Yes" ID="Tab1">
                    <Caption Language="En">
                      <CaptionNumber>Table 1</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Top 30 genes up-regulated in ZIKV infected hNPCs compared to controls</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <tgroup cols="5">
                      <colspec align="left" colname="c1" colnum="1"/>
                      <colspec align="left" colname="c2" colnum="2"/>
                      <colspec align="left" colname="c3" colnum="3"/>
                      <colspec align="char" char="." colname="c4" colnum="4"/>
                      <colspec align="char" char="." colname="c5" colnum="5"/>
                      <thead>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Gene symbol</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>Entrez</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Gene name</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>Log2 FC</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>p value</SimplePara>
                          </entry>
                        </row>
                      </thead>
                      <tbody>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>IFIT2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>3433</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Interferon-induced protein with tetratricopeptide repeats 2</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>5.22967</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.0051</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>TNFRSF14</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>8764</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Tumor necrosis factor receptor superfamily, member 14</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>3.4467</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>BHLHE41</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>79365</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Basic helix-loop-helix family, member e41</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>3.41193</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>SNORD116-4</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>100033416</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Small nucleolar RNA, C/D box 116-4</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>3.3541</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00065</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>CEBPB</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>1051</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>CCAAT/enhancer binding protein (C/EBP), beta</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>3.08608</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>SEC24D</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>9871</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>SEC24 family, member D (<Emphasis Type="Italic">S</Emphasis>. <Emphasis Type="Italic">cerevisiae</Emphasis>)</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>3.06648</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>CHAC1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>79094</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>ChaC, cation transport regulator homolog 1 (<Emphasis Type="Italic">E. coli</Emphasis>)</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.98802</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>CREB3L1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>90993</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>cAMP responsive element binding protein 3-like 1</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.9718</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>DDIT3</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>1649</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>DNA-damage-inducible transcript 3</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.94172</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>STC2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>8614</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Stanniocalcin 2</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.85446</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>IL20RB</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>53833</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Interleukin 20 receptor beta</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.74302</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>ADM2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>79924</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Adrenomedullin 2</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.73791</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>DDR2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>4921</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Discoidin domain receptor tyrosine kinase 2</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.68283</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>ULBP1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>80329</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>UL16 binding protein 1</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.6589</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>SLC7A11</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>23657</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Solute carrier family 7 (anionic amino acid transporter light chain, xc-system), member 11</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.55855</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>GABRR2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>2570</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Gamma-aminobutyric acid (GABA) A receptor, rho 2</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.54697</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00025</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>FOSL1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>8061</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>FOS-like antigen 1</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.54626</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>RELB</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>5971</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>v-rel reticuloendotheliosis viral oncogene homolog B</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.52167</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>BHLHE40</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>8553</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Basic helix-loop-helix family, member e40</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.50278</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>INHBE</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>83729</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Inhibin, beta E</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.48416</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>XBP1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>7494</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>X-box binding protein 1</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.48392</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>SELPLG</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>6404</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Selectin P ligand</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.47628</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>SLC7A5</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>8140</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Solute carrier family 7 (amino acid transporter light chain, L system), member 5</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.44283</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>ARHGAP9</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>64333</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Rho GTPase activating protein 9</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.42899</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>HERPUD1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>9709</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.38525</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>KLF15</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>28999</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Kruppel-like factor 15</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.36633</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>CDC42EP1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>11135</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>CDC42 effector protein (Rho GTPase binding) 1</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.35073</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>CEBPD</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>1052</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>CCAAT/enhancer binding protein (C/EBP), delta</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.34979</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00025</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>GAL3ST2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>64090</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Galactose-3-<Emphasis Type="Italic">O</Emphasis>-sulfotransferase 2</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.31589</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.0021</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>FAM129A</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>116496</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Family with sequence similarity 129, member A</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c4">
                            <SimplePara>2.28808</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                      </tbody>
                    </tgroup>
                  </Table> 
                           <Table Float="Yes" ID="Tab2">
                    <Caption Language="En">
                      <CaptionNumber>Table 2</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Top 30 genes down-regulated in ZIKV infected hNPCs compared to controls</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <tgroup cols="5">
                      <colspec align="left" colname="c1" colnum="1"/>
                      <colspec align="left" colname="c2" colnum="2"/>
                      <colspec align="left" colname="c3" colnum="3"/>
                      <colspec align="char" char="−" colname="c4" colnum="4"/>
                      <colspec align="char" char="." colname="c5" colnum="5"/>
                      <thead>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Gene symbol</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>Entrez</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Gene name</SimplePara>
                          </entry>
                          <entry align="left" colname="c4">
                            <SimplePara>Log2 FC</SimplePara>
                          </entry>
                          <entry align="left" colname="c5">
                            <SimplePara>p-value</SimplePara>
                          </entry>
                        </row>
                      </thead>
                      <tbody>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>SIGLEC10</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>89790</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Sialic acid binding Ig-like lectin 10</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−3.60664</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>CDC20B</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>166979</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Cell division cycle 20 homolog B (<Emphasis Type="Italic">S</Emphasis>. <Emphasis Type="Italic">cerevisiae</Emphasis>)</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−3.44083</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.0002</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>OR51E2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>81285</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Olfactory receptor, family 51, subfamily E, member 2</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−3.05742</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.0001</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>CCNO</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>10309</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Cyclin O</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−3.00562</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>SLCO4A1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>28231</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Solute carrier organic anion transporter family, member 4A1</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.97508</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.0229</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>SGPP2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>130367</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Sphingosine-1-phosphate phosphatase 2</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.69025</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00035</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>RRM2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>6241</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Ribonucleotide reductase M2</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.63783</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>SFXN2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>118980</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Sideroflexin 2</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.61672</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>COLEC12</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>81035</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Collectin sub-family member 12</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.60458</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>CHRNA1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>1134</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Cholinergic receptor, nicotinic, alpha 1 (muscle)</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.5688</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>PRR22</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>163154</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Proline rich 22</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.54683</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00045</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>DHFR</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>1719</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Dihydrofolate reductase</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.53145</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>MFI2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>4241</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.50748</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>MAPK15</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>225689</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Mitogen-activated protein kinase 15</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.46203</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>C21orf58</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>54058</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Chromosome 21 open reading frame 58</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.39697</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>SPEF1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>25876</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Sperm flagellar 1</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.39565</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>GHRL</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>51738</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Ghrelin/obestatin prepropeptide</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.35804</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00805</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>ATG16L2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>89849</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Autophagy related 16-like 2 (<Emphasis Type="Italic">S</Emphasis>. <Emphasis Type="Italic">cerevisiae</Emphasis>)</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.34225</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>CXCL14</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>9547</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Chemokine (C-X-C motif) ligand 14</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.33189</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.0015</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>SUSD2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>56241</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Sushi domain containing 2</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.28898</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>C6orf118</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>168090</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Chromosome 6 open reading frame 118</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.27987</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>DLX6-AS1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>285987</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>DLX6 antisense RNA 1</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.26662</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>ADAM28</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>10863</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>ADAM metallopeptidase domain 28</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.25906</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>NXPH2</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>11249</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Neurexophilin 2</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.22856</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>AQP7P1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>375719</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Aquaporin 7 pseudogene 1</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.2255</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>EFCAB1</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>79645</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>EF-hand calcium binding domain 1</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.19918</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>WNT8B</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>7479</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Wingless-type MMTV integration site family, member 8B</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.19366</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>PI15</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>51050</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Peptidase inhibitor 15</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.17615</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.00005</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>C1orf189</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>388701</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Chromosome 1 open reading frame 189</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.17531</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.01255</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>OLFML3</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>56944</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Olfactomedin-like 3</SimplePara>
                          </entry>
                          <entry align="char" char="−" colname="c4">
                            <SimplePara>−2.16835</SimplePara>
                          </entry>
                          <entry align="char" char="." colname="c5">
                            <SimplePara>0.0016</SimplePara>
                          </entry>
                        </row>
                      </tbody>
                    </tgroup>
                  </Table> 
                           <Figure Category="Standard" Float="Yes" ID="Fig1">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 1</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Comprehensive gene set gene ontology analysis. Gene ontology analysis was performed on hNPC genes whose expression was significantly altered following infection with ZIKV for 56 h. Transcript enrichment significance was determined using the human protein coding genome as the reference background. <Emphasis Type="Bold">a</Emphasis> Regulation of nucleic acid metabolism was the only biological process sub-ontology enriched with ZIKV up-regulated genes. Down-regulated genes were enriched for pathways related to cell cycle regulation and general metabolism. All significant terms are presented. <Emphasis Type="Bold">b</Emphasis> Cellular component enrichment indicated down-regulated genes generally associated with chromosomal regions, the extracellular matrix, and centrosomes. Up-regulated genes showed the most enrichment for the Golgi apparatus. Both up- and down-regulated genes were significantly enriched in nuclear sites. Enrichment scores were sorted by the most significant terms, and the top 11 compartments are represented. (q &lt; 0.05)</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO1">
                      <ImageObject Color="BlackWhite" FileRef="MediaObjects/13578_2016_110_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
                <Para ID="Par35">By also assessing cellular compartment sub-ontology, we elucidated the cellular location of the infection induced gene expression alterations (Fig. <InternalRef RefID="Fig1">1</InternalRef>b). Genes down-regulated by ZIKV were highly enriched in centromeric and nuclear sites, the extracellular matrix, and mitochondria. Furthermore, down-regulated genes were associated with exosomes, suggesting that the infection can influence exosome biology. Up-regulated genes were enriched specifically in the Golgi complex, the cytoplasm, and the monocytic leukemia zinc-finger protein/related factor (MOZ/MORF) histone acetyltransferase complex, which serves as a regulator of neural and hematopoietic stem-cell identity [<CitationRef CitationID="CR16">16</CitationRef>].</Para>
              </Section2>
              <Section2 ID="Sec4">
                <Heading>ZIKV DEGs represented in canonical human neurological diseases</Heading>
                <Para ID="Par36">To investigate whether ZIKV induced differentially expressed genes (DEGs) are related to the observed clinical phenotypes, comparisons were made between significant ZIKV DEGs and those related to the pathogenesis of human neurological diseases (Fig. <InternalRef RefID="Fig2">2</InternalRef>) (Table <InternalRef RefID="Tab3">3</InternalRef>). Considering that hNPCs were used for the RNA-seq study, our inquiry was limited to diseases of the nervous system. Using the MalaCards [<CitationRef CitationID="CR17">17</CitationRef>] integrated searchable database of human diseases, we selected six conditions for comparison. Each condition is a parent disease relating sub-categories of more specific diseases. For each condition, the number of ZIKV DEGs present in the MalaCards reference list is reported as the represented percentage. The number of total genes in each MalaCards reference list is plotted along the second y-axis (scatterplot). The condition with the most representation proved to be microcephaly, with 70 % of the 30 reference list genes present in the ZIKV DEGs. Since, epilepsy is a common microcephaly co-morbidly [<CitationRef CitationID="CR18">18</CitationRef>], it was unsurprising to discover there was 43 % representation of related genes. The more general group of congenital nervous system disorders also displayed a similarly high representation of ZIKV DEGs at 60 % of the total reference list. Since, there has also been an increase in reported cases of adult GBS in ZIKV affected areas [<CitationRef CitationID="CR2">2</CitationRef>, <CitationRef CitationID="CR3">3</CitationRef>], we investigated encephalitis, demyelinating diseases, and GBS specifically. While representation of ZIKV DEGs in these disease classifications were present, it was significantly less than congenital central nervous system (CNS) diseases.<Figure Category="Standard" Float="Yes" ID="Fig2">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 2</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>ZIKV DEGs mapped to canonical human disease gene sets. Using the MalaCards database of human diseases, diseases with established clinical significance to ZIKV infection were queried. ZIKV DEGs were then compared to reference gene list for each disease to determine a percentage of representation. Diseases related to congenital CNS disorders were most highly represented with ZIKV DEGs. Although less, representation of adult inflammatory and demyelinating diseases were also observed. (<Emphasis Type="Italic">Bars</Emphasis> % of ZIKV induced genes present in the reference list) (<Emphasis Type="Italic">Open circles</Emphasis> total number of genes in the disease reference list)</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO2">
                      <ImageObject Color="BlackWhite" FileRef="MediaObjects/13578_2016_110_Fig2_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
                    </MediaObject>
                  </Figure>
                           <Table Float="Yes" ID="Tab3">
                    <Caption Language="En">
                      <CaptionNumber>Table 3</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Neurological clinical phenotypes associated with ZIKV DEGs</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <tgroup cols="3">
                      <colspec align="left" colname="c1" colnum="1"/>
                      <colspec align="left" colname="c2" colnum="2"/>
                      <colspec align="left" colname="c3" colnum="3"/>
                      <thead>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>Disease</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>Gene symbol</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Gene name</SimplePara>
                          </entry>
                        </row>
                      </thead>
                      <tbody>
                        <row>
                          <entry align="left" colname="c1" morerows="20">
                            <SimplePara>Microcephaly</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>DYRK1A</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>MCPH1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Microcephalin 1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CASK</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Calcium/calmodulin-dependent serine protein kinase (MAGUK family)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>PHGDH</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Phosphoglycerate dehydrogenase</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>ARFGEF2</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>ADP-ribosylation factor guanine nucleotide-exchange factor 2</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>ASPM</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Asp (abnormal spindle) homolog, microcephaly associated</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CENPJ</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Centromere protein J</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CEP152</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Centrosomal protein 152 kDa</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>SLC25A19</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>WDR62</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>WD repeat domain 62</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CDK5RAP2</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>CDK5 regulatory subunit associated protein 2</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CASC5</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Cancer susceptibility candidate 5</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>NBN</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Nibrin</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>EFTUD2</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Elongation factor Tu GTP binding domain containing 2</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>IER3IP1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Immediate early response 3 interacting protein 1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>STIL</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>SCL/TAL1 interrupting locus</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CEP135</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Centrosomal protein 135 kDa</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>ZNF335</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Zinc finger protein 335</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>NDE1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>nudE nuclear distribution E homolog 1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>DIAPH1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Diaphanous homolog 1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>KIF11</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Kinesin family member 11</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1" morerows="19">
                            <SimplePara>Congenital nervous system disorders</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>MCPH1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Microcephalin 1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>ARFGEF2</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>TGIF1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>TGFB-induced factor homeobox 1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>GRIN2B</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Glutamate receptor, ionotropic, <Emphasis Type="Italic">N</Emphasis>-methyl <Emphasis Type="SmallCaps">d</Emphasis>-aspartate 2B</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>SLC12A5</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Solute carrier family 12 (potassium/chloride transporter), member 5</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>FLNA</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Filamin A, alpha</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>SIX3</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>SIX homeobox 3</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>SHH</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Sonic hedgehog</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CDK5RAP2</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>CDK5 regulatory subunit associated protein 2</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>NDE1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>nudE nuclear distribution E homolog 1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>WDR62</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>WD repeat domain 62</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>ASPM</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Asp (abnormal spindle) homolog, microcephaly associated</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CENPJ</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Centromere protein J</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>STIL</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>SCL/TAL1 interrupting locus</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>FKTN</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Fukutin</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>POMGNT1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Protein O−linked mannose beta1,2−N−acetylglucosaminyltransferase</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CEP152</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Centrosomal protein 152 kDa</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>POMT2</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Protein−O−mannosyltransferase 2</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>GLI2</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>GLI family zinc finger 2</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>ZNF335</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Zinc finger protein 335</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1" morerows="12">
                            <SimplePara>Epilepsy syndrome</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>CDKL5</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Cyclin−dependent kinase−like 5</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CSTB</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Cystatin B (stefin B)</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>TSC1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Tuberous sclerosis 1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CACNB4</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Calcium channel, voltage−dependent, beta 4 subunit</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CLCN2</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Chloride channel, voltage−sensitive 2</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>PCDH19</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Protocadherin 19</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>KCNQ2</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Potassium voltage−gated channel, KQT−like subfamily, member 2</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>CLN5</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Ceroid−lipofuscinosis, neuronal 5</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>ATP1A2</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>ATPase, Na +/K + transporting, alpha 2 polypeptide</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>LGI1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Leucine−rich, glioma inactivated 1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>SCN1B</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Sodium channel, voltage−gated, type I, beta subunit</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>ALDH5A1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Aldehyde dehydrogenase 5 family, member A1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>EFHC1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>EF−hand domain (C−terminal) containing 1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1" morerows="2">
                            <SimplePara>Encephalitis</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>DDX58</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>DEAD (Asp−Glu−Ala−Asp) box polypeptide 58</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>RPSA</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Ribosomal protein SA</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>TREX1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Three prime repair exonuclease 1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1" morerows="2">
                            <SimplePara>Demyelinating disease</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>PLP1</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Proteolipid protein 1</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>RTN4</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Reticulon 4</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c2">
                            <SimplePara>GALC</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Galactosylceramidase</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry align="left" colname="c1">
                            <SimplePara>GBS</SimplePara>
                          </entry>
                          <entry align="left" colname="c2">
                            <SimplePara>FAS</SimplePara>
                          </entry>
                          <entry align="left" colname="c3">
                            <SimplePara>Fas (TNF receptor superfamily, member 6)</SimplePara>
                          </entry>
                        </row>
                      </tbody>
                    </tgroup>
                  </Table>
                        </Para>
              </Section2>
              <Section2 ID="Sec5">
                <Heading>GO network mapping reveals connections between hNPC ZIKV infection and the immune system</Heading>
                <Para ID="Par37">A wide variety of cell types outside the traditional immune system can respond to the threat of pathogens [<CitationRef CitationID="CR19">19</CitationRef>]. Thus, investigations were conducted to determine if infected hNPCs presented a pattern of gene expression consistent with a defense response. To visualize the intracellular networks regulating expression changes, a GO network map was generated (Fig. <InternalRef RefID="Fig3">3</InternalRef>). All significant ZIKV DEGs greater than 0.5 absolute log fold-change were loaded into Cytoscape [<CitationRef CitationID="CR20">20</CitationRef>], and gene ontology clustering was performed with the ClueGO plugin [<CitationRef CitationID="CR21">21</CitationRef>]. The human genome was used as the background with GO biological process and immune system terms queried for enrichment. GO terms for biological processes are denoted with a circle, while GO immune system terms are denoted with a triangle. As expected, nucleic acid metabolic processes were heavily enriched and connected, representing the majority of the network and indicating that they are not a directly connected to the immune system terms. Of the eight main networks identified, four were associated with immune system response. The identified networks were immune response, cytokine production, leukocyte activation, and defense response to other organisms. Additionally, cell cycle, negative regulation of macromolecule biosynthetic process, and cellular macromolecule metabolic process terms were represented.<Figure Category="Standard" Float="Yes" ID="Fig3">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 3</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Gene ontology functional network of biological process and immune system terms. All significantly altered genes greater than 0.5 fold-change were imported into Cytoscape and Gene Ontology clustering was performed with the ClueGO plugin. The human genome was used as the background with the GO biological process and immune system terms queried for enrichment. Terms were generated such that GO Term Fusion was implemented on pathways with a less than 0.01 q-value. Groupings with less than 3 connections were excluded from the final list of networks. Terms related to cytokine and chemokine production as well as general pathogen response formed networks independent of nucleic acid and macromolecule metabolic processes</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO3">
                      <ImageObject Color="Color" FileRef="MediaObjects/13578_2016_110_Fig3_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
              </Section2>
              <Section2 ID="Sec6">
                <Heading>Gene expression in ZIKV-infected hNPCs differs from the expression profile of CMV-infected hNPCs</Heading>
                <Para ID="Par38">A number of common human viruses are known to infect fetal NPCs, such as Herpes simplex virus 1 (HSV-1), CMV, human immunodeficiency virus (HIV), and Varicella-zoster virus (VZV), and are linked to the development of severe birth defects [<CitationRef CitationID="CR6">6</CitationRef>, <CitationRef CitationID="CR9">9</CitationRef>, <CitationRef CitationID="CR11">11</CitationRef>, <CitationRef CitationID="CR13">13</CitationRef>, <CitationRef CitationID="CR22">22</CitationRef>–<CitationRef CitationID="CR24">24</CitationRef>]. To explore if the alterations in immune related gene expression seen in ZIKV-infected hNPCs was consistent with other viral infections, we compared the ZIKV expression profile to that of CMV-infected human induced pluripotent stem (iPS) derived NPCs. This gene set provided well matched data for comparison, since the hNPCs in both studies were derived from iPS cells and implement Illumina transcript analysis [<CitationRef CitationID="CR9">9</CitationRef>, <CitationRef CitationID="CR23">23</CitationRef>]. Additionally, hNPCs have demonstrated permissiveness to both viruses and infection in early fetal development with either virus has been linked to similar congenital neurological defects [<CitationRef CitationID="CR9">9</CitationRef>, <CitationRef CitationID="CR11">11</CitationRef>, <CitationRef CitationID="CR23">23</CitationRef>, <CitationRef CitationID="CR24">24</CitationRef>].</Para>
                <Para ID="Par39">The significant CMV related DEGs were analyzed in the same manner as the ZIKV related DEGs, such that the significant biological pathways are reported as fold enrichment. Clustering the pathways enriched by either CMV or ZIKV infection revealed apparent differences in the functional pathway enrichment patterns (Fig. <InternalRef RefID="Fig4">4</InternalRef>). Forced clustering by functional pathway was used with hierarchical clustering within the groups implemented by rows. When hierarchical clustering is applied to columns, ZIKV up- and down-regulated gene pathways showed stronger similarity to each other than to CMV altered pathways (Fig. <InternalRef RefID="Fig4">4</InternalRef>a). Examination of the cytokine/chemokine specific pathways likewise indicated divergent expression profiles between viruses (Fig. <InternalRef RefID="Fig4">4</InternalRef>b). Several cytokine-regulated pathways were activated in ZIKV-infected NPCs, while CMV-infected hNPCs showed limited representation of these pathways. Interleukin-5 (IL-5), granulocyte-macrophage colony-stimulating factor (GM-CSF), and interleukin-3 (IL-3) mediated signaling were comparably enriched but associated with the down regulated genes in CMV but with the up regulated genes in the CMV set. Additionally, the pathogen response pathways highly represented in the ZIKV altered genes are not significantly enriched in either the CMV up or down regulated gene sets (Fig. <InternalRef RefID="Fig4">4</InternalRef>c). While both viruses can infect hNPCs and cause comparable birth defects, the apparent mechanism by which these birth defects are caused appears to be unrelated between viruses.<Figure Category="Standard" Float="Yes" ID="Fig4">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 4</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Divergent gene expression patterns in CMV and ZIKV-infected hNPCs. Genes significantly different between mock and cells infected with either CMV or ZIKV were processed identically and resulting significant biological pathways were mapped. Clustering was performed on the resulting pathways such that similar functions were grouped for clarity. The Cytokine/Chemokine and Pathogen Response clusters were enlarged to demonstrate the divergent pathway enrichment between ZIKV and CMV infection</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO4">
                      <ImageObject Color="Color" FileRef="MediaObjects/13578_2016_110_Fig4_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
              </Section2>
              <Section2 ID="Sec7">
                <Heading>Immune and inflammatory responses in ZIKV-infected hNPCs</Heading>
                <Para ID="Par40">Given that the immune response gene enrichment seen in ZIKV-infected hNPCs differed from CMV infection, we further investigated the potential inflammatory pathways involved. Inspection of the biological pathways significantly enriched for ZIKV DEGs revealed a pattern of immunological term enrichment in genes up-regulated by the virus. Using search terms classifying immune related pathways our query returned 24 immune related pathways out of the 178 total in the ZIKV up-regulated genes (Fig. <InternalRef RefID="Fig5">5</InternalRef>a). Of the 119 significantly enriched pathways of genes down-regulated by ZIKV infection, none were related to immune function (Fig. <InternalRef RefID="Fig5">5</InternalRef>a). Among the inflammatory pathways identified from the up-regulated genes, were the endosomal viral pathogen recognizing Toll-like receptor (TLR) 9 and TLR7/8 pathways which recognize CpG containing DNA and ssRNA, respectively [<CitationRef CitationID="CR25">25</CitationRef>]. TLR receptor signaling is primarily mediated through the adaptor protein myeloid differentiation primary response gene 88 (MyD88) in response to infection [<CitationRef CitationID="CR26">26</CitationRef>]. Other TLRs are located on the plasma membrane and recognize a wide variety of pathogen associated molecules [<CitationRef CitationID="CR25">25</CitationRef>] and were thus classified as pathogen response pathways. Additionally, several canonical inflammatory pathways were activated, including tumor necrosis factor (TNF) receptor pathways, interferon gamma (IFN-γ) signaling pathway, pathways involved in interleukin (IL)-1, IL-2, IL-3, IL-5, IL-6, IL-12, IL-23, C-X-C motif chemokine 12 (CXCL12)/CXCR4, pathway and GM-CSF mediated pathway (Fig. <InternalRef RefID="Fig5">5</InternalRef>b).<Figure Category="Standard" Float="Yes" ID="Fig5">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 5</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Immune specific biological pathways enriched in up-regulated genes. <Emphasis Type="Bold">a</Emphasis> The biological pathways associated with ZIKV transcript changes were filtered to include top immune specific pathways. <Emphasis Type="Bold">b</Emphasis> Using a FDR q-value &lt;0.05, several top immune function pathways were enriched for the up-regulated gene set, although none of the pathways were enriched for significant down-regulated transcripts. The q-values for the pathway enrichment are annotated along the <Emphasis Type="Italic">left panel</Emphasis> as the <Emphasis Type="Italic">dot plot</Emphasis>. <Emphasis Type="Bold">c</Emphasis> Using tissue specific expression databases, up- and down-regulated genes were probed for immune related cells and tissues. Innate and adaptive immune system components were represented in both lists. (<Emphasis Type="Italic">q</Emphasis> &lt; <Emphasis Type="Italic">0.05</Emphasis>)</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO5">
                      <ImageObject Color="Color" FileRef="MediaObjects/13578_2016_110_Fig5_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
                <Para ID="Par41">Cell and tissue type analysis of the whole ZIKV DEG gene set revealed representation of tissue types associated with immune and hematological function (Fig. <InternalRef RefID="Fig5">5</InternalRef>c). Tissue and cell types exclusively associated with ZIKV up-regulated genes included the bone marrow, erythrocytes, and platelets. B-cells and dendritic cells were the only cell types exclusive to the down-regulated gene set. Both up- and down-regulated genes were enriched for monocytes, T-cells, leukocytes, and the thymus. The immune specific enrichment of the genes differentially expressed in ZIKV-infected hNPCs indicate involvement of both the innate and adaptive immune system. Dendritic cells are important antigen-presenting cells (APC) while T- and B-cells are primarily responsible for adaptive response. This enrichment points to a role for ZIKV inducing NPCs to take on a yet unclear immune-modulating phenotype.</Para>
              </Section2>
              <Section2 ID="Sec8">
                <Heading>Analysis of cytokine/chemokine associated intracellular signaling pathways</Heading>
                <Para ID="Par42">The two major immune cell pathways that control the production of inflammatory cytokines can be classified as being nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and signal transducer and activator of transcription (STAT) protein family dependent. Both NF-κB and STAT family-members are transcription factors that induce gene expression upon stimulation by wide variety of ligands. Figure <InternalRef RefID="Fig6">6</InternalRef> illustrates simplified versions of these pathways activated in ZIKV-infected NPCs. The pathogens (represented as pathogen-associated molecular patterns, PAMP) and TLR 7/8/9 pathways enriched in the ZIKV up-regulated genes (Fig. <InternalRef RefID="Fig4">4</InternalRef>), induce gene expression primarily through nuclear translocation of NF-κB. Other NF-κB mediated pathways enriched in ZIKV up-regulated genes were C-X-C chemokine receptor type 4 (CXCR4), CD40, TNF, and IL-1 signaling (Fig. <InternalRef RefID="Fig4">4</InternalRef>). STAT family induced genes can also result in inflammatory cytokine production upon activation of plasma membrane receptors. The enriched STAT family related signaling pathways were IFN-γ, IL-6, and IL-12 in the ZIKV up-regulated genes (Fig. <InternalRef RefID="Fig4">4</InternalRef>).<Figure Category="Standard" Float="Yes" ID="Fig6">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 6</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Activation of NF-κB and STATs signaling pathway in ZIKV-infected hNPCs. Cytokines (IL-1 and TNF-α), PAMPs, CD40 and CXCL12 interact with their receptors resulting in activation of the NF-κB pathway. IFN-γ, IL-6 and IL-12 binding to their receptors induces STAT dimerization and translocation to the nucleus. Activation of both the canonical NF-κB and STAT signaling pathways, results in the production of numerous inflammatory cytokines.</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO6">
                      <ImageObject Color="Color" FileRef="MediaObjects/13578_2016_110_Fig6_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec9">
              <Heading>Discussion</Heading>
              <Para ID="Par43">Our results show that collectively, ZIKV induced transcriptomic alterations are associated with established clinical pathologies. Following viral infection there is a reallocation of host nucleic acids and other metabolites towards viral specific replication processes [<CitationRef CitationID="CR12">12</CitationRef>], thus the enrichment of biological processes related to nucleic acid metabolism is an expected finding, as well as the enrichment of cell cycle regulation. The cell cycle perturbations of infected cells suggest the initiation of a G<Subscript>1</Subscript>/S checkpoint and impaired progression through G<Subscript>1</Subscript> [<CitationRef CitationID="CR9">9</CitationRef>]. A possible explanation for these cell cycle abnormalities could be inhibition of S-phase progression due to limited nucleic acid reserves as the virus reallocates them for its own replication. Down-regulation of critical epigenetic markers represents a possible driver for abnormal gene expression in infected cells. If NPCs in the developing human brain are diverted from normal development, it can result in conditions like microcephaly. Moreover, this raises questions about the possible long-term neurological effects in adult following ZIKV infection of adult neural progenitors. Although, the ZIKV associated clinical phenotypes were highly enriched for congenital CNS disorders, comparatively few genes were associated with adult CNS inflammation and demyelination diseases. This may be the due to the fact that the current study implemented the MR766 Ugandan isolate which has not been associated with an increased incidence of GBS and myelitis. As a result, future studies that employ more neoteric strains will likely observe increased representation of related genes.</Para>
              <Para ID="Par44">The significant enrichment of canonical immune system pathways in ZIKV-infected hNPCs proved to be another unexpected finding. Our study provides evidence at the transcriptional level that two major mediators of inflammation, NF-κB and the STAT family of proteins, regulate inflammatory response in hNPCs. NF-κB is one of the main transcriptional factors activated in response to pro-inflammatory cytokines, such as TNF-α and IL-1. It is also triggered by TLRs via pathogen-associated molecular patterns (PAMPs). The Janus Kinase (JAK)-Signal transducer and activator of transcription (STAT) pathway is also a major signaling pathway that regulates inflammation and mediates the responses of target cells to inflammatory cytokines. Activation of these pathways has a central role in inflammation through the regulation of genes encoding pro-inflammatory cytokines, chemokines, and inducible enzymes such as cyclooxygenase-2 (COX2) and inducible nitric oxide synthase (iNOS) [<CitationRef CitationID="CR27">27</CitationRef>]. Moreover, it has recently been reported that ZIKV-infected fetal brains display a number of inflammatory markers, including diffuse astrogliosis, and activations of macrophages and microglia [<CitationRef CitationID="CR9">9</CitationRef>]. It is conceivable that ZIKV-infected NPCs may exert immunomodulatory and inflammatory effects on CNS cells such as neurons as well as astrocytes in an autocrine, paracrine, and juxtacrine manner, thus amplifying brain inflammation. Interestingly, although congenital CMV infection can also result in microcephaly and general impaired brain development [<CitationRef CitationID="CR24">24</CitationRef>], the inflammatory signals were not observed in CMV-infected hNPCs. The significance of this is still under investigation.</Para>
              <Para ID="Par45">With the currently limited molecular data regarding transcriptomic alterations in infected host cells, large scale analysis is difficult. In spite of this, we present analysis of the currently available data in an effort to guide future studies. The RNA-seq was performed on only one infected cell type, hNPCs, thus we implemented stringent Benjamini Hochberg (BH) [<CitationRef CitationID="CR28">28</CitationRef>] false discovery rate (FDR) q-value cut-offs to limit false positives in enriched pathways. The use of the older MR766 isolate for the experiments likewise limits extrapolation of the results, even though it shares 88.9 % nucleotide and 96.5 % amino acid identity with the current strain [<CitationRef CitationID="CR29">29</CitationRef>]. Considering that reported pathogenicity has been increasing over time, the presented data likely represents a milder host response should any host transcript differences exist.</Para>
            </Section1>
            <Section1 ID="Sec10">
              <Heading>Conclusion</Heading>
              <Para ID="Par46">In conclusion, we report that ZIKV infection induces alterations to NPC immune response gene expression. While the primary infection typically occurs through the bite of an infected mosquito, the mechanism for entry into the restricted CNS is currently unclear. Presumably the specific physiology of the fetal blood brain barrier is permissible to ZIKV as it is to other viruses [<CitationRef CitationID="CR24">24</CitationRef>]. Regardless, it has been shown that the virus can infect NPCs with high efficiency leading to increased apoptosis [<CitationRef CitationID="CR9">9</CitationRef>]. In addition, the presented study is the first to report enrichment of numerous pro-inflammatory pathways in ZIKV-infected hNPCs, indicating that hNPCs are capable of activating pro-inflammatory immune system pathways following viral infections. This represents, in addition to direct activation of apoptotic pathways, a mechanism by which the virus could induce cell death via the propagation a cytotoxic pro-inflammatory environment in the CNS. Although it is possible that ZIKV can infect immune cells in a similar manner as the related Dengue virus [<CitationRef CitationID="CR30">30</CitationRef>–<CitationRef CitationID="CR33">33</CitationRef>], the ability of ZIKV to infect hNPCs may exacerbate CNS inflammation. Consequently, a better understanding of the cellular and molecular mechanisms regulation of the cross-talk between NPCs, CNS resident cells, and immune cells may be crucial for the development of effective strategies to treat ZIKV infection.</Para>
            </Section1>
            <Section1 ID="Sec11">
              <Heading>Methods</Heading>
              <Section2 ID="Sec12">
                <Heading>Gene sets and expression analysis</Heading>
                <Para ID="Par47">We analyzed the transcriptomic sequencing (RNA-seq) data (GEO: GSE78711) of ZIKV (MR766) infected human neural progenitor cells (hNPCs). Briefly, Tang et al. infected hNPCs derived from human induced pluripotent stem (iPS) cells with ZIKV. The infected hNPCs were incubated for 56 h, a time frame already proven sufficient for a greater than 60 % infection rate. RNA extracted from ZIKV-infected samples and mock infected samples was used for library generation and sequencing [<CitationRef CitationID="CR9">9</CitationRef>]. For comparison to the ZIKV-infected hNPCs, the expression data from iPCS derived NPCs infected with human CMV (Ad169) was implemented (GEO: GSE35295). The cells were infected with CMV, and the RNA was extracted 24 after infection for analysis on an Illumina HumanHT-12 V4.0 expression beadchip. Three biological replicates for control and infected cells were used, and a list of significantly altered genes were generated with a BH FDR q-value cut-off of &lt; 0.05 [<CitationRef CitationID="CR23">23</CitationRef>].</Para>
              </Section2>
              <Section2 ID="Sec13">
                <Heading>Availability of data and materials</Heading>
                <Para ID="Par48">The datasets supporting the conclusions of this article are available in the gene expression omnibus (GEO) repository, <ExternalRef>
                    <RefSource>http://www.ncbi.nlm.nih.gov/geo/</RefSource>
                    <RefTarget Address="http://www.ncbi.nlm.nih.gov/geo/" TargetType="URL"/>
                  </ExternalRef>.</Para>
              </Section2>
              <Section2 ID="Sec14">
                <Heading>Biological process and cellular compartment analysis</Heading>
                <Para ID="Par49">Using FunRich [<CitationRef CitationID="CR34">34</CitationRef>], up- and down-regulated genes with associated Log<Subscript>2</Subscript> FCs were analyzed for enrichment against the human annotated genome. Biological process, cellular compartment, and biological pathway significance was defined as a FDR q-value less than 0.05. All significant biological processes were presented. All 11 significant cellular compartments for the ZIKV up-regulated genes were presented, along with the top 11 most significant pathways enriched for ZIKV down-regulated genes.</Para>
              </Section2>
              <Section2 ID="Sec15">
                <Heading>Subsetting for immune specific biological pathway enrichment</Heading>
                <Para ID="Par50">The significant biological pathways associated with both ZIKV up- and down-regulated genes were filtered such that non-immune specific biological pathways were excluded. Significance was defined as a FDR q-value less than 0.05.</Para>
              </Section2>
              <Section2 ID="Sec16">
                <Heading>ZIKV genes associated with clinical phenotypes</Heading>
                <Para ID="Par51">Clinically relevant diseases associated with ZIKV DEGs were queried using the MalaCards [<CitationRef CitationID="CR17">17</CitationRef>] integrated database of human diseases. The absolute percentage of ZIKV DEGs present in the reference list derived from MalaCards was reported, as well as the total number of genes in the reference list.</Para>
              </Section2>
              <Section2 ID="Sec17">
                <Heading>Gene ontology network analysis</Heading>
                <Para ID="Par52">DEGs with an absolute fold change greater than 0.5 were imported to Cytoscape [<CitationRef CitationID="CR20">20</CitationRef>], where Gene Ontology clustering was performed using the ClueGO plugin [<CitationRef CitationID="CR21">21</CitationRef>]. The human genome was used as the background, and the GO biological process and GO immune system terms were queried for enrichment. Terms were generated such that GO Term Fusion was implemented for pathways with a less than 0.01 FDR q-value. Groups with less than three connections were excluded from the final network.</Para>
              </Section2>
              <Section2 ID="Sec18">
                <Heading>R packages</Heading>
                <Para ID="Par53">Heatmaps generated with the Bioconductor package ComplexHeatmap [<CitationRef CitationID="CR35">35</CitationRef>] within the R statistical computing environment [<CitationRef CitationID="CR36">36</CitationRef>].</Para>
              </Section2>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/13578_2016_Article_110.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Acknowledgments>
              <Heading>Authors’ contributions</Heading>
              <SimplePara>AR and YR conceived and designed the study. AR analyzed the data. AR, DB, JW, RN, JF and YR interpreted the results and discussed the study. AR, DB and YR wrote the paper. All authors read and approved the final manuscript.</SimplePara>
              <FormalPara ID="FPar1" RenderingStyle="Style1">
                <Heading>Acknowledgements</Heading>
                <Para ID="Par54">Thanks to Stephanie Hurwitz for review of the manuscript. This work was supported by the National Institutes of Health (R01GM100474 and R01GM072611).</Para>
              </FormalPara>
              <FormalPara ID="FPar2" RenderingStyle="Style1">
                <Heading>Competing interests</Heading>
                <Para ID="Par55">The authors declare that they have no competing interests.</Para>
              </FormalPara>
            </Acknowledgments>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Faye</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CC</Initials>
                    <FamilyName>Freire</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Iamarino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Faye</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JV</Initials>
                    <FamilyName>Oliveira</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Diallo</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2014</Year>
                  <ArticleTitle Language="En">Molecular evolution of Zika virus during its emergence in the 20(th) century</ArticleTitle>
                  <JournalTitle>PLoS Negl Trop Dis</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>e2636</FirstPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1371/journal.pntd.0002636</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>24421913</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3888466</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Faye O, Freire CC, Iamarino A, Faye O, de Oliveira JV, Diallo M, et al. Molecular evolution of Zika virus during its emergence in the 20(th) century. PLoS Negl Trop Dis. 2014;8(1):e2636.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HM</Initials>
                    <FamilyName>Lazear</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MS</Initials>
                    <FamilyName>Diamond</FamilyName>
                  </BibAuthorName>
                  <Year>2016</Year>
                  <ArticleTitle Language="En">Zika virus: new clinical syndromes and its emergence in the western hemisphere</ArticleTitle>
                  <JournalTitle>J Virol</JournalTitle>
                  <BibArticleDOI>10.1128/JVI.00252-16</BibArticleDOI>
                  <Occurrence Type="PID">
                    <Handle>26962217</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lazear HM, Diamond MS. Zika virus: new clinical syndromes and its emergence in the western hemisphere. J Virol. 2016. doi:<ExternalRef>
                    <RefSource>10.1128/JVI.00252-16</RefSource>
                    <RefTarget Address="10.1128/JVI.00252-16" TargetType="DOI"/>
                  </ExternalRef>.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V-M</Initials>
                    <FamilyName>Cao-Lormeau</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Blake</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Mons</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Lastère</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Roche</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Vanhomwegen</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2016</Year>
                  <ArticleTitle Language="En">Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study</ArticleTitle>
                  <JournalTitle>Lancet</JournalTitle>
                  <VolumeID>387</VolumeID>
                  <IssueID>10027</IssueID>
                  <FirstPage>1531</FirstPage>
                  <LastPage>1539</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0140-6736(16)00562-6</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>26948433</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cao-Lormeau V-M, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, et al. Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibUnstructured>Zammarchi L, Tappe D, Fortuna C, Remoli ME, Gunther S, Venturi G, et al. Zika virus infection in a traveller returning to Europe from Brazil, March 2015. Euro Surveill. 2015;20(23). doi:<ExternalRef><RefSource>10.2807/1560-7917.ES2015.20.23.21153</RefSource><RefTarget Address="10.2807/1560-7917.ES2015.20.23.21153" TargetType="DOI"/></ExternalRef>.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JG</Initials>
                    <FamilyName>Olson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TG</Initials>
                    <FamilyName>Ksiazek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <NoInitials/>
                    <FamilyName>Suhandiman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <NoInitials/>
                    <FamilyName>Triwibowo</FamilyName>
                  </BibAuthorName>
                  <Year>1981</Year>
                  <ArticleTitle Language="En">Zika virus, a cause of fever in Central Java, Indonesia</ArticleTitle>
                  <JournalTitle>Trans R Soc Trop Med Hyg</JournalTitle>
                  <VolumeID>75</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>389</FirstPage>
                  <LastPage>393</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL387gvVKmsg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0035-9203(81)90100-0</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>6275577</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Olson JG, Ksiazek TG, Suhandiman, Triwibowo. Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg. 1981;75(3):389–93.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CV</Initials>
                    <FamilyName>Ventura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maia</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Bravo-Filho</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AL</Initials>
                    <FamilyName>Góis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Belfort</FamilyName>
                    <Suffix>Jr</Suffix>
                  </BibAuthorName>
                  <Year>2016</Year>
                  <ArticleTitle Language="En">Zika virus in Brazil and macular atrophy in a child with microcephaly</ArticleTitle>
                  <JournalTitle>Lancet</JournalTitle>
                  <VolumeID>387</VolumeID>
                  <IssueID>10015</IssueID>
                  <FirstPage>228</FirstPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0140-6736(16)00006-4</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>26775125</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ventura CV, Maia M, Bravo-Filho V, Góis AL, Belfort R Jr. Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet. 2016;387(10015):228.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Mlakar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Korva</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Tul</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Popović</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Poljšak-Prijatelj</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Mraz</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2016</Year>
                  <ArticleTitle Language="En">Zika virus associated with microcephaly</ArticleTitle>
                  <JournalTitle>N Engl J Med</JournalTitle>
                  <VolumeID>374</VolumeID>
                  <IssueID>10</IssueID>
                  <FirstPage>951</FirstPage>
                  <LastPage>958</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJMoa1600651</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>26862926</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M, Mraz J, et al. Zika virus associated with microcephaly. N Engl J Med. 2016;374(10):951–8.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Kleber de Oliveira</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Cortez-Escalante</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WT</Initials>
                    <FamilyName>Oliveira</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GM</Initials>
                    <FamilyName>Carmo</FamilyName>
                    <Particle>do</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Henriques</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GE</Initials>
                    <FamilyName>Coelho</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2016</Year>
                  <ArticleTitle Language="En">Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy—Brazil, 2015</ArticleTitle>
                  <JournalTitle>MMWR Morb Mortal Wkly Rep</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <IssueID>9</IssueID>
                  <FirstPage>242</FirstPage>
                  <LastPage>247</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.15585/mmwr.mm6509e2</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>26963593</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kleber de Oliveira W, Cortez-Escalante J, De Oliveira WT, do Carmo GM, Henriques CM, Coelho GE, et al. Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy—Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(9):242–7.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Tang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Hammack</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Ogden Sarah</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Wen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Qian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2016</Year>
                  <ArticleTitle Language="En">Zika virus infects human cortical neural progenitors and attenuates their growth</ArticleTitle>
                  <JournalTitle>Cell Stem Cell</JournalTitle>
                  <BibArticleDOI>10.1016/j.stem.2016.02.016</BibArticleDOI>
                </BibArticle>
                <BibUnstructured>Tang H, Hammack C, Ogden Sarah C, Wen Z, Qian X, Li Y, et al. Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell. 2016. doi:<ExternalRef>
                    <RefSource>10.1016/j.stem.2016.02.016</RefSource>
                    <RefTarget Address="10.1016/j.stem.2016.02.016" TargetType="DOI"/>
                  </ExternalRef>.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Dollard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Grosse</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DS</Initials>
                    <FamilyName>Ross</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection</ArticleTitle>
                  <JournalTitle>Rev Med Virol</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>355</FirstPage>
                  <LastPage>363</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/rmv.544</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>17542052</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355–63.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MH</Initials>
                    <FamilyName>Luo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Hannemann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Kulkarni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PH</Initials>
                    <FamilyName>Schwartz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>O’Dowd</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EA</Initials>
                    <FamilyName>Fortunato</FamilyName>
                  </BibAuthorName>
                  <Year>2010</Year>
                  <ArticleTitle Language="En">Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells</ArticleTitle>
                  <JournalTitle>J Virol</JournalTitle>
                  <VolumeID>84</VolumeID>
                  <IssueID>7</IssueID>
                  <FirstPage>3528</FirstPage>
                  <LastPage>3541</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC3cXktFOgtL0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1128/JVI.02161-09</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>20071566</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>2838134</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Luo MH, Hannemann H, Kulkarni AS, Schwartz PH, O’Dowd JM, Fortunato EA. Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells. J Virol. 2010;84(7):3528–41.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EM</Initials>
                    <FamilyName>Martin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Malec</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Sved</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TS</Initials>
                    <FamilyName>Work</FamilyName>
                  </BibAuthorName>
                  <Year>1961</Year>
                  <ArticleTitle Language="En">Studies on protein and nucleic acid metabolism in virus-infected mammalian cells. 1. Encephalomyocarditis virus in Krebs II mouse-ascites-tumour cells</ArticleTitle>
                  <JournalTitle>Biochem J</JournalTitle>
                  <VolumeID>80</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>585</FirstPage>
                  <LastPage>597</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaF3MXhsVGgsbo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1042/bj0800585</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>13767335</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>1243272</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Martin EM, Malec J, Sved S, Work TS. Studies on protein and nucleic acid metabolism in virus-infected mammalian cells. 1. Encephalomyocarditis virus in Krebs II mouse-ascites-tumour cells. Biochem J. 1961;80(3):585–97.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PP</Initials>
                    <FamilyName>Garcez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EC</Initials>
                    <FamilyName>Loiola</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Madeiro da Costa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LM</Initials>
                    <FamilyName>Higa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Trindade</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Delvecchio</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2016</Year>
                  <ArticleTitle Language="En">Zika virus impairs growth in human neurospheres and brain organoids</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <BibArticleDOI>10.1126/science.aaf6116</BibArticleDOI>
                  <Occurrence Type="PID">
                    <Handle>27064148</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Garcez PP, Loiola EC, Madeiro da Costa R, Higa LM, Trindade P, Delvecchio R, et al. Zika virus impairs growth in human neurospheres and brain organoids. Science. 2016. doi:<ExternalRef>
                    <RefSource>10.1126/science.aaf6116</RefSource>
                    <RefTarget Address="10.1126/science.aaf6116" TargetType="DOI"/>
                  </ExternalRef>.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Mahmood</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Ahmad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Hassan</FamilyName>
                  </BibAuthorName>
                  <Year>2011</Year>
                  <ArticleTitle Language="En">Autosomal recessive primary microcephaly (MCPH): clinical manifestations, genetic heterogeneity and mutation continuum</ArticleTitle>
                  <JournalTitle>Orphanet J Rare Dis</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>39</FirstPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1186/1750-1172-6-39</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>21668957</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3123551</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mahmood S, Ahmad W, Hassan MJ. Autosomal recessive primary microcephaly (MCPH): clinical manifestations, genetic heterogeneity and mutation continuum. Orphanet J Rare Dis. 2011;6:39.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Bond</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Roberts</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Springell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SB</Initials>
                    <FamilyName>Lizarraga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Scott</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Higgins</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain size</ArticleTitle>
                  <JournalTitle>Nat Genet</JournalTitle>
                  <VolumeID>37</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>353</FirstPage>
                  <LastPage>355</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXislClsr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/ng1539</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15793586</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bond J, Roberts E, Springell K, Lizarraga SB, Scott S, Higgins J, et al. A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain size. Nat Genet. 2005;37(4):353–5.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>XJ</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ullah</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells</ArticleTitle>
                  <JournalTitle>Oncogene</JournalTitle>
                  <VolumeID>26</VolumeID>
                  <IssueID>37</IssueID>
                  <FirstPage>5408</FirstPage>
                  <LastPage>5419</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2sXovFeku7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.onc.1210609</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>17694082</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yang XJ, Ullah M. MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells. Oncogene. 2007;26(37):5408–19.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibUnstructured>Rappaport N, Nativ N, Stelzer G, Twik M, Guan-Golan Y, Iny Stein T, et al. MalaCards: an integrated compendium for diseases and their annotation. Database (Oxford). 2013;bat018. doi:<ExternalRef><RefSource>10.1093/database/bat018</RefSource><RefTarget Address="10.1093/database/bat018" TargetType="DOI"/></ExternalRef>.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Aggarwal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Mittal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Patil</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Debnath</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Rai</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Clinical profile of children with developmental delay and microcephaly</ArticleTitle>
                  <JournalTitle>J Neurosci Rural Pract</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>288</FirstPage>
                  <LastPage>291</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.4103/0976-3147.118781</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>24250161</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3821414</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Aggarwal A, Mittal H, Patil R, Debnath S, Rai A. Clinical profile of children with developmental delay and microcephaly. J Neurosci Rural Pract. 2013;4(3):288–91.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HJ</Initials>
                    <FamilyName>Anders</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Banas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Schlondorff</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Signaling danger: toll-like receptors and their potential roles in kidney disease</ArticleTitle>
                  <JournalTitle>J Am Soc Nephrol</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>854</FirstPage>
                  <LastPage>867</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXitFWrsLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/01.ASN.0000121781.89599.16</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15034087</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Anders HJ, Banas B, Schlondorff D. Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol. 2004;15(4):854–67.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Shannon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Markiel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Ozier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NS</Initials>
                    <FamilyName>Baliga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Ramage</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Cytoscape: a software environment for integrated models of biomolecular interaction networks</ArticleTitle>
                  <JournalTitle>Genome Res</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <IssueID>11</IssueID>
                  <FirstPage>2498</FirstPage>
                  <LastPage>2504</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXovFWrtr4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1101/gr.1239303</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>14597658</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>403769</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Bindea</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Mlecnik</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Hackl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Charoentong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Tosolini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Kirilovsky</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2009</Year>
                  <ArticleTitle Language="En">ClueGO: a cytoscape plug-into decipher functionally grouped gene ontology and pathway annotation networks</ArticleTitle>
                  <JournalTitle>Bioinformatics</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <IssueID>8</IssueID>
                  <FirstPage>1091</FirstPage>
                  <LastPage>1093</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD1MXksVeiu74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/bioinformatics/btp101</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>19237447</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>2666812</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a cytoscape plug-into decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091–3.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Nowakowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Pollen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Lullo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Sandoval-Espinosa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bershteyn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AR</Initials>
                    <FamilyName>Kriegstein</FamilyName>
                  </BibAuthorName>
                  <Year>2016</Year>
                  <ArticleTitle Language="En">Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells</ArticleTitle>
                  <JournalTitle>Cell Stem Cell</JournalTitle>
                  <BibArticleDOI>10.1016/j.stem.2016.03.012</BibArticleDOI>
                  <Occurrence Type="PID">
                    <Handle>27038591</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nowakowski TJ, Pollen AA, Di Lullo E, Sandoval-Espinosa C, Bershteyn M, Kriegstein AR. Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells. Cell Stem Cell. 2016. doi:<ExternalRef>
                    <RefSource>10.1016/j.stem.2016.03.012</RefSource>
                    <RefTarget Address="10.1016/j.stem.2016.03.012" TargetType="DOI"/>
                  </ExternalRef>.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>D’Aiuto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Maio</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Heath</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Raimondi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Milosevic</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Watson</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2012</Year>
                  <ArticleTitle Language="En">Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells</ArticleTitle>
                  <JournalTitle>PLoS One</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <IssueID>11</IssueID>
                  <FirstPage>e49700</FirstPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1371/journal.pone.0049700</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23209593</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3507916</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>D’Aiuto L, Di Maio R, Heath B, Raimondi G, Milosevic J, Watson AM, et al. Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells. PLoS One. 2012;7(11):e49700.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MCJ</Initials>
                    <FamilyName>Cheeran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Lokensgard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MR</Initials>
                    <FamilyName>Schleiss</FamilyName>
                  </BibAuthorName>
                  <Year>2009</Year>
                  <ArticleTitle Language="En">Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention</ArticleTitle>
                  <JournalTitle>Clin Microbiol Rev</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>99</FirstPage>
                  <LastPage>126</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD1MXnslKrs7s%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1128/CMR.00023-08</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>19136436</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>2620634</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cheeran MCJ, Lokensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev. 2009;22(1):99–126.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Takeda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Akira</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">TLR signaling pathways</ArticleTitle>
                  <JournalTitle>Curr Protoc Immunol</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>3</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXntVOnsA%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/j.smim.2003.10.003</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Takeda K, Akira S. TLR signaling pathways. Curr Protoc Immunol. 2004;16(1):3–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Akira</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Takeda</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Toll-like receptor signalling</ArticleTitle>
                  <JournalTitle>Nat Rev Immunol</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <IssueID>7</IssueID>
                  <FirstPage>499</FirstPage>
                  <LastPage>511</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXlt1Cqur0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nri1391</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15229469</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499–511.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Baud</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Karin</FamilyName>
                  </BibAuthorName>
                  <Year>2009</Year>
                  <ArticleTitle Language="En">Is NF-[kappa]B a good target for cancer therapy? hopes and pitfalls</ArticleTitle>
                  <JournalTitle>Nat Rev Drug Discov</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>33</FirstPage>
                  <LastPage>40</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD1cXhsFCku7%2FM</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nrd2781</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>19116625</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>2729321</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Baud V, Karin M. Is NF-[kappa]B a good target for cancer therapy? hopes and pitfalls. Nat Rev Drug Discov. 2009;8(1):33–40.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Benjamini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Hochberg</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Controlling the false discovery rate: a practical and powerful approach to multiple testing</ArticleTitle>
                  <JournalTitle>J R Stat Soc Series B Stat Methodol</JournalTitle>
                  <BibArticleDOI>10.2307/2346101</BibArticleDOI>
                </BibArticle>
                <BibUnstructured>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995. doi:<ExternalRef>
                    <RefSource>10.2307/2346101</RefSource>
                    <RefTarget Address="10.2307/2346101" TargetType="DOI"/>
                  </ExternalRef>.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RS</Initials>
                    <FamilyName>Lanciotti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>OL</Initials>
                    <FamilyName>Kosoy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Laven</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JO</Initials>
                    <FamilyName>Velez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Lambert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Johnson</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2008</Year>
                  <ArticleTitle Language="En">Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007</ArticleTitle>
                  <JournalTitle>Emerg Infect Dis</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <IssueID>8</IssueID>
                  <FirstPage>1232</FirstPage>
                  <LastPage>1239</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD1cXhtVCnsb%2FK</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.3201/eid1408.080287</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>18680646</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>2600394</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14(8):1232–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CP</Initials>
                    <FamilyName>Simmons</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Farrar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Vinh Chau</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Wills</FamilyName>
                  </BibAuthorName>
                  <Year>2012</Year>
                  <ArticleTitle Language="En">Dengue</ArticleTitle>
                  <JournalTitle>N Engl J Med</JournalTitle>
                  <VolumeID>366</VolumeID>
                  <IssueID>15</IssueID>
                  <FirstPage>1423</FirstPage>
                  <LastPage>1432</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC38XlslOrsbw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJMra1110265</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>22494122</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Simmons CP, Farrar JJ, van Vinh Chau N, Wills B. Dengue. N Engl J Med. 2012;366(15):1423–32.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Nakao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Lai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NS</Initials>
                    <FamilyName>Young</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>74</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>1235</FirstPage>
                  <LastPage>1240</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL1Mzlt1ymuw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>2765663</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nakao S, Lai CJ, Young NS. Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood. 1989;74(4):1235–40.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JF</Initials>
                    <FamilyName>Kelley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PH</Initials>
                    <FamilyName>Kaufusi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EM</Initials>
                    <FamilyName>Volper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VR</Initials>
                    <FamilyName>Nerurkar</FamilyName>
                  </BibAuthorName>
                  <Year>2011</Year>
                  <ArticleTitle Language="En">Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines</ArticleTitle>
                  <JournalTitle>Virology</JournalTitle>
                  <VolumeID>418</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>27</FirstPage>
                  <LastPage>39</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC3MXhtV2msr7I</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.virol.2011.07.006</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>21810535</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3184475</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kelley JF, Kaufusi PH, Volper EM, Nerurkar VR. Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines. Virology. 2011;418(1):27–39.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>VF</Initials>
                    <FamilyName>Russa</FamilyName>
                    <Particle>La</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BL</Initials>
                    <FamilyName>Innis</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Mechanisms of dengue virus-induced bone marrow suppression</ArticleTitle>
                  <JournalTitle>Baillieres Clin Haematol</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>249</FirstPage>
                  <LastPage>270</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0950-3536(05)80240-9</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>7663049</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>La Russa VF, Innis BL. Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin Haematol. 1995;8(1):249–70.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Pathan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Keerthikumar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CS</Initials>
                    <FamilyName>Ang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Gangoda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CY</Initials>
                    <FamilyName>Quek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NA</Initials>
                    <FamilyName>Williamson</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2015</Year>
                  <ArticleTitle Language="En">FunRich: an open access standalone functional enrichment and interaction network analysis tool</ArticleTitle>
                  <JournalTitle>Proteomics</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <IssueID>15</IssueID>
                  <FirstPage>2597</FirstPage>
                  <LastPage>2601</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC2MXhtVSitb%2FP</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/pmic.201400515</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>25921073</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pathan M, Keerthikumar S, Ang CS, Gangoda L, Quek CY, Williamson NA, et al. FunRich: an open access standalone functional enrichment and interaction network analysis tool. Proteomics. 2015;15(15):2597–601.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibUnstructured>Zuguang G. ComplexHeatmap: making complex heatmaps. R package version 1.6.0 ed2015.</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>36.</CitationNumber>
                <BibBook>
                  <InstitutionalAuthorName>R Core Team</InstitutionalAuthorName>
                  <Year>2015</Year>
                  <BookTitle>R: a language and environment for statistical computing</BookTitle>
                  <PublisherName>R Foundation for Statistical Computing</PublisherName>
                  <PublisherLocation>Vienna</PublisherLocation>
                </BibBook>
                <BibUnstructured>R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2015.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
